GRI Bio's total assets for Q4 2024 were $5.74M, an increase of 5.13% from the previous quarter. GRI total liabilities were $1.71M for the fiscal quarter, a -5.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.